97597 vs 11042: Which Wound Debridement Code to Use
The clinical decision between CPT 97597 and 11042 — selective vs excisional debridement criteria, the documentation that determines which code is correct, and the revenue difference.
Damon Ebanks
Medipyxis
97597 vs 11042: The Core Question
Every wound debridement comes down to one clinical question: did the clinician debride to viable tissue, or did they remove surface devitalized tissue without reaching the viable plane underneath?
If the answer is surface removal only -- clearing slough, fibrin, loose eschar, biofilm from the wound bed without cutting to bleeding tissue -- the code is 97597 (selective debridement, first 20 sq cm).
If the answer is excision to viable tissue -- using a sharp instrument to cut past devitalized layers until healthy, bleeding tissue is exposed at the wound base or margins -- the code is 11042 (excisional debridement to skin/subcutaneous tissue, first 20 sq cm).
The instrument does not decide. The tissue depth reached decides.
The Documentation Test
Read the clinician's note after the visit and ask: does this note describe reaching viable tissue?
A 97597 note reads like this: "Removed adherent fibrinous slough from wound bed using curette. Wound bed after debridement shows granulation tissue. No active bleeding." The wound bed after debridement looks the same as before -- granulation tissue was already present underneath the slough.
An 11042 note reads like this: "Excised necrotic tissue and adherent eschar using scalpel to the level of viable subcutaneous tissue. Active bleeding at wound base and margins after debridement. Wound bed now shows healthy, well-perfused subcutaneous fat." The wound bed changed because tissue was excised, not just cleared.
If the note says "debridement performed" without describing what tissue layer was reached or whether bleeding occurred, the documentation does not support either code on audit. The note must answer the question the code is designed to answer.
Decision Criteria Summary
Bill 97597 when:
- Devitalized tissue (slough, eschar, fibrin, biofilm) was removed from the wound surface
- The debridement stayed within the nonviable tissue layer
- The wound bed after debridement shows granulation tissue that was already present
- No active bleeding at the debridement site
- The procedure is routine wound maintenance
Bill 11042 when:
- A sharp instrument was used to cut through devitalized tissue to a viable tissue plane
- Active bleeding is present at the wound base or margins after debridement
- The note describes reaching subcutaneous tissue (11042), muscle/fascia (11043), or bone (11044)
- The wound bed visibly changed -- newly exposed viable tissue, not just cleared surface debris
- The clinical situation required aggressive removal to achieve a clean wound base
The Revenue Difference
The 2026 Medicare national average reimbursement for 97597 is approximately $80-$90 in the office setting. For 11042, the average is approximately $125-$150. That is a $40-$60 gap per visit.
For a clinician seeing 20 wound patients per week who performs debridement at each visit, undercoding excisional debridement as selective costs approximately $800-$1,200 per week, or $40,000-$60,000 annually. That is not a rounding error. It is a structural revenue leak caused by incomplete documentation.
The Most Common Undercoding Scenario
The typical pattern: a clinician performs excisional debridement -- scalpel, tissue excised to viable base, bleeding at margins -- but writes a note that says "debridement of wound performed, slough removed." The biller reads the note, sees no mention of tissue depth or bleeding, and codes 97597 because the documentation does not support anything higher.
The clinician did the work. The note did not capture it. The claim goes out at $80 instead of $140.
This is not a billing problem. It is a documentation problem. The fix is not to code higher -- it is to document what actually happened. When the clinician describes the tissue depth reached and documents active bleeding, the correct code follows directly from the clinical record.
For a complete walkthrough of both code families including add-on codes, modifier rules, and NCCI bundling, see our debridement billing guide. For modifier usage on debridement claims, see our billing modifiers reference.